Humana (HUM) Net Debt uz 2026. g. 4. marts.
Humana Net Debt
Net Debt
0USD
Pēdējo reizi atjaunināts: 2026. g. 4. marts
Humana Net Debt ir 2026 0 USD. Humana Net Debt bija 2025 0 USD. Tas ir samazinājies par % zemāks salīdzinājumā ar iepriekšējo gadu.
Humana Akciju analīze
Ko dara Humana? Humana Inc. is an American company that specializes in health and social services. It was founded in 1961 in Louisville, Kentucky by David Jones and Wendell Cherry to acquire and operate hospital chains. Today, Humana offers a wide range of health and social services for customers of all ages.
The business model of Humana is based on providing health and social services to private, government, and commercial customers. The company aims to improve the health and well-being of people by providing them access to high-quality and affordable services in healthcare, life and disability insurance, and care.
Humana's various divisions are tailored to the needs of customers. The Humana Health division includes offerings such as health insurance, medical care, and prevention programs to avoid illnesses. The Humana Dental division provides comprehensive dental care to customers, including preventive exams, routine treatments, and repairs. Therapy and medical devices are also included in Humana's offerings.
The company has also focused on senior care. In recent years, Humana has made several acquisitions of companies that offer care services for seniors. This allows them to provide customers with a comprehensive range of physical and mental care services. Building nursing homes and financing hospices are also part of Humana's offerings.
In addition to the mentioned services, Humana also offers health promotion and prevention programs, such as sports programs and mental health training for individuals with depression or anxiety disorders.
Humana is a globally operating company based in Louisville, Kentucky and serves customers in the USA and internationally. The company employs over 41,000 employees and has an annual revenue of approximately $56.9 billion.
Overall, Humana is a company that focuses on improving the health and well-being of customers worldwide. It offers a wide range of health and social services for people of all ages and from all walks of life. The commitment to senior care allows Humana to focus on a sustainable future for its customers, while the offering of prevention programs ensures the preservation of a healthy society and economy. Humana ir viens no populārākajiem uzņēmumiem Eulerpool.com.
Bieži uzdotie jautājumi par Humana akciju
Eulerpool jūs atradīsiet Net Debt Humana pilnīgu vēsturisko attīstību kopš 2006. gada – ar ikgadējām vērtībām, grafikiem un detalizētām analīzēm.
Balance Sheet — Humana
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsPašu kapitālsSaistībasParādsaistībasCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
Akcienu ieguldījumu plāni piedāvā investoriem pievilcīgu iespēju ilgtermiņā uzkrāt kapitālu. Viens no galvenajiem priekšrocībām ir tā sauktais Vidējās izmaksas efekts: ieguldot regulāri noteiktu summu akcijās vai akciju fondos, automātiski tiek iegādāts vairāk daļu, kad cenas ir zemas, un mazāk, kad tās ir augstas. Tas laika gaitā var novest pie izdevīgākas vidējās cenas par daļu. Turklāt akcienu ieguldījumu plāni nodrošina piekļuvi dārgām akcijām arī mazajiem investoriem, jo tiem var pievienoties jau ar nelielām summu. Regulāra ieguldījumu veikšana arī veicina disciplinētu ieguldījumu stratēģiju un palīdz izvairīties no emocionāliem lēmumiem, piemēram, impulsīvas pirkšanas vai pārdošanas. Turklāt investori gūst labumu no potenciālās akciju vērtības pieauguma un no dividendēm, kuras var reinvestēt, tādejādi pastiprinot procentu uz procentu efektu un līdz ar to investētā kapitāla augšanu.
All Key Metrics — Humana
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Pašu kapitāls
- Saistības
- Parādsaistības
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth